| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $508.8M | +104.0% |
| Cost of Revenue | $20.2M | +136.1% |
| R&D Expense | $341.4M | -20.2% |
| SG&A Expense | $359.3M | +21.7% |
| Pre-tax Income | -$65.9M | +87.0% |
| Income Tax | $1.2M | +26.7% |
| Net Income | -$67.1M | +86.8% |
| EPS (Basic) | -$1.07 | +87.2% |
| EPS (Diluted) | -$1.07 | +87.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.0M | +43.1% |
| Accounts Receivable | $75.8M | +77.0% |
| Inventory | $13.6M | -35.9% |
| Current Assets | $742.7M | -8.1% |
| Total Assets | $1.18B | +12.4% |
| Current Liabilities | $260.8M | +21.3% |
| Total Liabilities | $881.1M | -4.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$192.6M | +55.9% |
| Capital Expenditures | $4.6M | -71.2% |
| Investing Cash Flow | -$47.5M | -117.3% |
| Financing Cash Flow | $273.1M | +129.1% |
| Free Cash Flow | -$197.2M | +56.5% |
| Stockholders' Equity |
| $298.7M |
| +128.7% |